Alzheimer's disease is associated with removal of the synaptic protein ADAM10

May 8, 2013

Alzheimer's disease is characterized by the accumulation of neurotoxic β-amyloid peptide (A-beta). ADAM10, a protein that resides in the neural synapses, has previously been shown to prevent the formation of A-beta.

In this issue of the Journal of Clinical Investigation, Monica Di Luca and colleagues at the University of Milan in Milan, Italy, report that ADAM10 is removed from synapses through association with the protein AP2.

Strikingly, the association between ADAM10 and AP2 was increased in homogenates from Alzheimer's disease (AD) patients compared to healthy controls.

was shown to influence the level and activity of ADAM10 in synapses and its association with AP2.

These studies identify pathological mechanisms associated with AD that control the localization of proteins at the synapse.

Explore further: New findings contradict dominant theory in Alzheimer's disease

More information: Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease J Clin Invest. doi:10.1172/JCI65401

Related Stories

Recommended for you

Brain's immune system triggers frontotemporal dementia

April 22, 2016

Frontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain's synaptic connections, according ...

Does fungus cause Alzheimer's?

October 15, 2015

Traces of fungus have been discovered in the brains of Alzheimer's sufferers, researchers said Thursday, relaunching the question: might the disease be caused by an infectious microbe?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.